Last A$0.81 AUD
Change Today -0.03 / -3.59%
Volume 126.3K
As of 1:38 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

nanosonics ltd (NAN) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/23/14 - A$0.96
52 Week Low
08/5/13 - A$0.71
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANOSONICS LTD (NAN)

Related News

No related news articles were found.

nanosonics ltd (NAN) Related Businessweek News

No Related Businessweek News Found

nanosonics ltd (NAN) Details

Nanosonics Limited, together with its subsidiaries, is engaged in the research, development, and commercialization of infection control and decontamination products, and related technologies. The company also manufactures and distributes trophon EPR ultrasound probe disinfector, and its associated consumables and accessories for use in the treatment of healthcare-acquired infections. It has operations primarily in North America, Europe, Australia, and New Zealand. The company was incorporated in 2000 and is based in Alexandria, Australia.

Founded in 2000

nanosonics ltd (NAN) Top Compensated Officers

Chief Financial Officer and Company Secretary
Total Annual Compensation: A$314.6K
Chief Operations Officer
Total Annual Compensation: A$253.8K
Head of Research, Design and Development
Total Annual Compensation: A$198.6K
Head of Global Services
Total Annual Compensation: A$168.8K
Chairman of Advisory Board, President of Tech...
Total Annual Compensation: A$342.9K
Compensation as of Fiscal Year 2013.

nanosonics ltd (NAN) Key Developments

Nanosonics Limited Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 01:30 PM

Nanosonics Limited Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 01:30 PM. Venue: Rydges Lakeland Resort, Queenstown, New Zealand. Speakers: Michael C. Kavanagh, Chief Executive Officer, President, Director and Chairman of Remuneration Committee.

Nanosonics Limited Announces Earnings Results for the Third Quarter and Sales Results for the Nine Months Ended March 31, 2014

Nanosonics Limited announced earnings results for the third quarter and sales results for the nine months ended March 31, 2014. For the quarter, sales were up 24% on the prior corresponding period to $5.220 million compared to $4.207 million for the same period last year. At the end of the quarter, the company reported $2.220 million operating cash flow, which included the $1.5 million R&D Tax Incentive. For the first three quarters of 2014, year-to- date sales rose 73% to $14.9 million equal those of the entire 2013 financial year, with another quarter still remaining in 2014.

Nanosonics Limited, Q3 2014 Earnings Call, Apr 29, 2014

Nanosonics Limited, Q3 2014 Earnings Call, Apr 29, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NAN:AU A$0.81 AUD -0.03

NAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NAN.
View Industry Companies

Industry Analysis


Industry Average

Valuation NAN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11.6x
Price/Book 12.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 10.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOSONICS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at